14-74260844-AGAG-AGAGGAG
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2
The NM_182894.3(VSX2):c.1022_1024dupAGG(p.Glu341dup) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,567,122 control chromosomes in the GnomAD database, including 28 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0068 ( 14 hom., cov: 33)
Exomes 𝑓: 0.00069 ( 14 hom. )
Consequence
VSX2
NM_182894.3 disruptive_inframe_insertion
NM_182894.3 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.50
Genes affected
VSX2 (HGNC:1975): (visual system homeobox 2) This gene encodes a homeobox protein originally described as a retina-specific transcription factor. Mutations in this gene are associated with microphthalmia, cataracts and iris abnormalities. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_182894.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 14-74260844-A-AGAG is Benign according to our data. Variant chr14-74260844-A-AGAG is described in ClinVar as [Benign]. Clinvar id is 536260.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00685 (1043/152278) while in subpopulation AFR AF= 0.0238 (990/41552). AF 95% confidence interval is 0.0226. There are 14 homozygotes in gnomad4. There are 493 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSX2 | NM_182894.3 | c.1022_1024dupAGG | p.Glu341dup | disruptive_inframe_insertion | 5/5 | ENST00000261980.3 | NP_878314.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSX2 | ENST00000261980.3 | c.1022_1024dupAGG | p.Glu341dup | disruptive_inframe_insertion | 5/5 | 1 | NM_182894.3 | ENSP00000261980.2 |
Frequencies
GnomAD3 genomes AF: 0.00686 AC: 1044AN: 152160Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1044
AN:
152160
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00150 AC: 261AN: 174474Hom.: 4 AF XY: 0.00109 AC XY: 102AN XY: 93416
GnomAD3 exomes
AF:
AC:
261
AN:
174474
Hom.:
AF XY:
AC XY:
102
AN XY:
93416
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000693 AC: 980AN: 1414844Hom.: 14 Cov.: 31 AF XY: 0.000583 AC XY: 408AN XY: 699304
GnomAD4 exome
AF:
AC:
980
AN:
1414844
Hom.:
Cov.:
31
AF XY:
AC XY:
408
AN XY:
699304
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00685 AC: 1043AN: 152278Hom.: 14 Cov.: 33 AF XY: 0.00662 AC XY: 493AN XY: 74462
GnomAD4 genome
AF:
AC:
1043
AN:
152278
Hom.:
Cov.:
33
AF XY:
AC XY:
493
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microphthalmia Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 14, 2020 | - - |
Isolated microphthalmia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at